Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06229860 · ClinicalTrials.gov registry record
Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia
A clinical trial of Chronic Myeloid Leukemia and Chronic Phase Chronic Myelogenous Leukemia, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- 75
- Enrollment target
- 1
- Study location
NCT06229860: Recruiting study of Chronic Myeloid Leukemia and Chronic Phase Chronic Myelogenous Leukemia, sponsored by University of California, Irvine.
NCT06229860 is a study of Chronic Myeloid Leukemia and Chronic Phase Chronic Myelogenous Leukemia that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 75 participants, below the 208-participant average among 35 other Chronic Myeloid Leukemia trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06229860, a study of Chronic Myeloid Leukemia and Chronic Phase Chronic Myelogenous Leukemia, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- 75 participants
- Enrollment target
- 1
- Study location
Study Summary
This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
Primary Outcome
This will be measured by Morisky Medication Adherence Scale (MMAS), an 8-item tool related to adherence behavior include forgetfulness, stopping medication because of worsening of symptoms or improvement in health condition, and inconvenience of continuing medication. Each item is scored 0 or 1 depending on whether the patient answers yes or no, with a minimum score of 0 and maximum score of 8
Conditions Studied
Interventions
- OTHER Interview
Study Locations (1)
California
- Chao Family Comprehensive Cancer Center University of California, Irvine - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2024-01-25 |
| Est. Completion | 2026-12 |
What NCT06229860 shows while recruiting
NCT06229860 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 208-participant average among 35 other Chronic Myeloid Leukemia trials with a reported enrollment target (64% lower).
The record links to 2 conditions, with Chronic Myeloid Leukemia appearing as the primary indexed condition, and to 1 intervention - of which Interview is the first listed.
NCT06229860 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT06229860 about?
NCT06229860 is a clinical study titled "Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia". This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.
What is the current status of trial NCT06229860?
This trial is currently recruiting. The enrollment target is 75 participants. The study started on 2024-01-25. Estimated completion is 2026-12.
What conditions does trial NCT06229860 study?
This clinical trial studies the following conditions: Chronic Myeloid Leukemia, Chronic Phase Chronic Myelogenous Leukemia.
What interventions are being tested in trial NCT06229860?
The interventions under investigation include: Interview (OTHER).
Who is sponsoring clinical trial NCT06229860?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06229860 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Myeloid Leukemia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06229860's enrollment target sits among peer trials
75 15th of 35 higher than 20 of 35 other Chronic Myeloid Leukemia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Chronic Myeloid Leukemia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
RECRUITING · Phase 1
-
Study of Olverembatinib (HQP1351) in Patients With CP-CML
RECRUITING · Phase 3
-
Safety And Efficacy Of TKI Cessation For CML Patients With Stable Molecular Response In A Real World Population
RECRUITING · Phase 2
-
KRT-232 and TKI Study in Chronic Myeloid Leukemia
RECRUITING · Phase 1
-
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
RECRUITING · Phase 1
-
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI